DEVELOPMENT OF ALOPECIA DURING TREATMENT WITH A TUMOR NECROSIS FACTOR-ALPHA INHIBITOR IN A FEMALE PATIENT WITH PSORIATIC ARTHRITS: A CLINICAL CASE

DEVELOPMENT OF ALOPECIA DURING TREATMENT WITH A TUMOR NECROSIS FACTOR-ALPHA INHIBITOR IN A FEMALE PATIENT WITH PSORIATIC ARTHRITS: A CLINICAL CASE

Objective: to describe a case of the total development of alopecia in a female patient with psoriatic arthritis during treatment with a tumor necrosis factor-αlpha (TNF-α) inhibitor. Materials and methods. Patient I., aged 36 years has been followed up at the Kazan’ Center of Rheumatic Diseases and...

Full description

Bibliographic Details
Main Authors: R. G. Mukhina, L. I. Myasoutova, A. G. Vasilyev, R. O. Demidov, G. A. Semenova
Format: Article
Language:Russian
Published: ABV-press 2016-06-01
Series:Klinicist
Subjects:
psoriasis
psoriatic arthritis
adverse drug reaction
drug-induced alopecia
basic therapy
cytostatics
leflunomide
biologics
tumor necrosis factor-alpha inhibitor
infliximab
ustekinumab
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/245

Internet

https://klinitsist.abvpress.ru/Klin/article/view/245

Similar Items